Given the investor's beginner status, long-term preference, and available capital, ESAB is not a strong buy at the moment. The stock lacks immediate positive catalysts, faces declining financial performance, and has mixed sentiment from analysts and trading trends. Holding off for now would be a prudent decision.
The MACD is positive but contracting, RSI is neutral at 44.195, and moving averages are converging, indicating no clear trend. The stock closed at $98.93, below the pivot point of $99.269, with key support at $94.803. The technical indicators suggest a neutral to slightly bearish outlook.

Hedge funds are significantly increasing their positions, with a 127,921.66% rise in buying activity. Analysts maintain a generally positive long-term outlook, citing growth catalysts like the Eddyfi acquisition and potential EPS inflection in the second half of 2026.
Insiders are selling heavily, with a 2,355.33% increase in selling activity. Financial performance in Q4 2025 showed a significant decline in net income (-29.35%), EPS (-30.23%), and gross margin (-7.14%). The Iran conflict and higher oil prices have negatively impacted demand for ESAB's solutions.
In Q4 2025, revenue grew by 7.49% YoY to $720.99M, but net income dropped by 29.35% YoY to $37.001M. EPS fell by 30.23% to $0.60, and gross margin declined by 7.14% to 35.76%. The financials indicate declining profitability despite revenue growth.
Analysts have lowered price targets recently, with the latest targets ranging from $130 to $142. However, the majority maintain Buy or Outperform ratings, citing long-term growth potential and strategic acquisitions like Eddyfi. Tactical risks and near-term headwinds are noted, but the long-term outlook remains cautiously optimistic.